Company registration number 06837314 (England and Wales)
THE CAMPBELL CLINIC LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025
PAGES FOR FILING WITH REGISTRAR
THE CAMPBELL CLINIC LIMITED
CONTENTS
Page
Accountants' report
1
Balance sheet
2 - 3
Notes to the financial statements
4 - 10
THE CAMPBELL CLINIC LIMITED
ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF THE CAMPBELL CLINIC LIMITED FOR THE YEAR ENDED 31 JANUARY 2025
- 1 -
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of The Campbell Clinic Limited for the year ended 31 January 2025 which comprise, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.
This report is made solely to the board of directors of The Campbell Clinic Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of The Campbell Clinic Limited and state those matters that we have agreed to state to the board of directors of The Campbell Clinic Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than The Campbell Clinic Limited and its board of directors as a body, for our work or for this report.
It is your duty to ensure that The Campbell Clinic Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of The Campbell Clinic Limited. You consider that The Campbell Clinic Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of The Campbell Clinic Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Ashgates Corporate Services Limited
5 Prospect Place
Millennium Way
Pride Park
Derby
DE24 8HG
23 July 2025
THE CAMPBELL CLINIC LIMITED
BALANCE SHEET
AS AT
31 JANUARY 2025
31 January 2025
- 2 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
460,997
372,245
Investments
4
645,500
483,500
1,106,497
855,745
Current assets
Stocks
22,499
20,499
Debtors
5
71,742
27,529
Cash at bank and in hand
752,442
682,229
846,683
730,257
Creditors: amounts falling due within one year
6
(451,312)
(366,389)
Net current assets
395,371
363,868
Total assets less current liabilities
1,501,868
1,219,613
Provisions for liabilities
(83,877)
(90,833)
Net assets
1,417,991
1,128,780
Capital and reserves
Called up share capital
7
200,000
200,000
Profit and loss reserves
1,217,991
928,780
Total equity
1,417,991
1,128,780
THE CAMPBELL CLINIC LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 JANUARY 2025
31 January 2025
- 3 -
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
For the financial year ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 18 July 2025 and are signed on its behalf by:
H Brown
Director
Company registration number 06837314 (England and Wales)
THE CAMPBELL CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025
- 4 -
1
Accounting policies
Company information
The Campbell Clinic Limited is a private company limited by shares incorporated in England and Wales. The registered office is 5 Prospect Place, Millennium Way, Pride Park, Derby, DE24 8HG.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.
THE CAMPBELL CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
1
Accounting policies
(Continued)
- 5 -
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Freehold land and buildings
2% straight line
Plant and machinery
15% reducing balance
Fixtures and fittings
15% reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.5
Fixed asset investments
Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.
Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.
1.6
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
THE CAMPBELL CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
1
Accounting policies
(Continued)
- 6 -
1.7
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
THE CAMPBELL CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
1
Accounting policies
(Continued)
- 7 -
1.8
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
39
36
THE CAMPBELL CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
- 8 -
3
Tangible fixed assets
Freehold land and buildings
Plant and machinery
Fixtures and fittings
Total
£
£
£
£
Cost
At 1 February 2024
505,476
123,746
629,222
Additions
125,491
9,599
12,132
147,222
Disposals
(995)
(995)
At 31 January 2025
125,491
515,075
134,883
775,449
Depreciation and impairment
At 1 February 2024
205,990
50,987
256,977
Depreciation charged in the year
46,059
11,782
57,841
Eliminated in respect of disposals
(366)
(366)
At 31 January 2025
252,049
62,403
314,452
Carrying amount
At 31 January 2025
125,491
263,026
72,480
460,997
At 31 January 2024
299,486
72,759
372,245
4
Fixed asset investments
2025
2024
£
£
Other investments other than loans
645,500
483,500
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 February 2024
483,500
Additions
162,000
At 31 January 2025
645,500
Carrying amount
At 31 January 2025
645,500
At 31 January 2024
483,500
THE CAMPBELL CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
- 9 -
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
38,442
17,909
Amounts owed by group undertakings and companies under common control
25,870
Other debtors
7,430
9,620
71,742
27,529
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
196,004
184,030
Amounts owed to group undertakings and companies under common control
117,787
Taxation and social security
90,320
141,658
Other creditors
47,201
40,701
451,312
366,389
THE CAMPBELL CLINIC LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2025
- 10 -
7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
200,000
200,000
200,000
200,000
8
Financial commitments, guarantees and contingencies
Amounts not provided for in the balance sheet
The total amount of financial commitments not included in the balance sheet is £320,000 (2024 - £480,000).
9
Related party transactions
Summary of transactions with other related parties
Directors of the company
At the balance sheet date amounts owed to the directors amounted to £35,044 (2024 - £28,648).
10
Parent and ultimate parent undertaking
The company's immediate parent is Colin Campbell 2011 Limited, incorporated in England.
The ultimate controlling party is Colin Campbell.
11
Events after the reporting date
After the balance sheet date the following dividends were voted:
£161,843 on ordinary shares
2025-01-312024-02-01falsefalsefalse23 July 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityC CampbellA CampbellH Brown068373142024-02-012025-01-31068373142025-01-31068373142024-01-3106837314core:LandBuildingscore:OwnedOrFreeholdAssets2025-01-3106837314core:PlantMachinery2025-01-3106837314core:ComputerEquipment2025-01-3106837314core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-3106837314core:PlantMachinery2024-01-3106837314core:ComputerEquipment2024-01-3106837314core:CurrentFinancialInstrumentscore:WithinOneYear2025-01-3106837314core:CurrentFinancialInstrumentscore:WithinOneYear2024-01-3106837314core:CurrentFinancialInstruments2025-01-3106837314core:CurrentFinancialInstruments2024-01-3106837314core:ShareCapital2025-01-3106837314core:ShareCapital2024-01-3106837314core:RetainedEarningsAccumulatedLosses2025-01-3106837314core:RetainedEarningsAccumulatedLosses2024-01-3106837314core:ShareCapitalOrdinaryShareClass12025-01-3106837314core:ShareCapitalOrdinaryShareClass12024-01-3106837314bus:Director32024-02-012025-01-3106837314core:LandBuildingscore:OwnedOrFreeholdAssets2024-02-012025-01-3106837314core:PlantMachinery2024-02-012025-01-3106837314core:ComputerEquipment2024-02-012025-01-31068373142023-02-012024-01-3106837314core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-3106837314core:PlantMachinery2024-01-3106837314core:ComputerEquipment2024-01-31068373142024-01-3106837314core:WithinOneYear2025-01-3106837314core:WithinOneYear2024-01-3106837314bus:OrdinaryShareClass12024-02-012025-01-3106837314bus:OrdinaryShareClass12025-01-3106837314bus:OrdinaryShareClass12024-01-3106837314bus:PrivateLimitedCompanyLtd2024-02-012025-01-3106837314bus:SmallCompaniesRegimeForAccounts2024-02-012025-01-3106837314bus:FRS1022024-02-012025-01-3106837314bus:AuditExemptWithAccountantsReport2024-02-012025-01-3106837314bus:Director12024-02-012025-01-3106837314bus:Director22024-02-012025-01-3106837314bus:FullAccounts2024-02-012025-01-31xbrli:purexbrli:sharesiso4217:GBP